Aayush Wellness has launched "Lung Care Tablets," marking its entry into India’s ₹18,913 Cr respiratory healthcare market.

This expansion strengthens the company's prevention-led healthcare vision and broadens its nutraceutical portfolio.

The new product addresses growing health challenges from smoking, air pollution, and environmental exposure.

India's respiratory therapeutic segment recorded sales of ₹18,912.64 crore in 2025, showing 10% year-on-year growth.

This move demonstrates Aayush Wellness' intent to build a broader, health-risk-led portfolio, aiming for sustained innovation and long-term value creation for investors.